No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs111633367 |
chr15:56298507-56298508 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs201837887 |
chr15:56298524-56298525 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs566824272 |
chr15:56298576-56298577 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs548134212 |
chr15:56298616-56298617 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs113646661 |
chr15:56298637-56298638 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs143683874 |
chr15:56298664-56298665 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs550636574 |
chr15:56298680-56298681 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs151065397 |
chr15:56298721-56298722 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs141331463 |
chr15:56298739-56298740 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs547180879 |
chr15:56298741-56298742 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs567004674 |
chr15:56298748-56298749 |
Active TSS Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs536167262 |
chr15:56298819-56298820 |
Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs555367740 |
chr15:56298839-56298840 |
Bivalent/Poised TSS Active TSS Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs558857119 |
chr15:56299006-56299007 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs575297601 |
chr15:56299037-56299038 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs145120251 |
chr15:56299057-56299058 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs376835805 |
chr15:56299080-56299081 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs540016437 |
chr15:56299119-56299120 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs189370980 |
chr15:56299121-56299122 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs573827925 |
chr15:56299131-56299132 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs182210564 |
chr15:56299147-56299148 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs75760999 |
chr15:56299198-56299199 |
Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs569897944 |
chr15:56299213-56299214 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs530807571 |
chr15:56299218-56299219 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs62046379 |
chr15:56299233-56299234 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs564383350 |
chr15:56299252-56299253 |
Active TSS Bivalent/Poised TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs28571735 |
chr15:56299271-56299272 |
Active TSS Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs367942930 |
chr15:56299310-56299311 |
Active TSS Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs546849307 |
chr15:56299311-56299312 |
Active TSS Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs62046380 |
chr15:56299364-56299365 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs138977625 |
chr15:56299393-56299394 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs7176495 |
chr15:56299411-56299412 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs140708650 |
chr15:56299416-56299417 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs569618302 |
chr15:56299417-56299418 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs537833184 |
chr15:56299419-56299420 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs557799741 |
chr15:56299423-56299424 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs571209218 |
chr15:56299441-56299442 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs566176909 |
chr15:56299444-56299445 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs533911324 |
chr15:56299445-56299446 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs553617077 |
chr15:56299454-56299455 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs573755970 |
chr15:56299455-56299456 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs187247328 |
chr15:56299462-56299463 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs191621651 |
chr15:56299480-56299481 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs570223471 |
chr15:56299483-56299484 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs556028111 |
chr15:56299490-56299491 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs575939570 |
chr15:56299522-56299523 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs544153979 |
chr15:56299538-56299539 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs564526121 |
chr15:56299542-56299543 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs533234494 |
chr15:56299634-56299635 |
Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs576404191 |
chr15:56299677-56299678 |
Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|